This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 25-31 May 2024 and includes updates on avian influenza, respiratory viruses, invasive meningococcal disease, mass gatherings for Hajj in Saudi Arabia, cholera, chikungunya, dengue, and poliomyelitis.
This framework describes the building blocks and actions that ECDC will use to support and EU/EEA countries and the European Commission to achieve the Sustainable Development Goal (SDG).
In 2022, 27 European Union/European Economic Area (EU/EEA) countries reported 731 echinococcosis cases. Of these, 299 (41%) cases were reported as Echinococcus granulosus sensu lato, 185 (25%) as E. multilocularis and 247 (34%) as an unknown species.
ECDC and the WHO Regional Office for Europe (WHO/Europe) recently concluded a crucial joint meeting focused on enhancing tuberculosis (TB) surveillance and monitoring across the WHO European Region.
In a concerted effort to combat healthcare-associated infections (HAIs) and antimicrobial resistance (AMR), the European Centre for Disease Prevention and Control (ECDC) and the Belgian EU Presidency on 6-7 May co-hosted a conference at the national public health institute of Belgium, Sciensano, in Brussels.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.
Infographic showing the key indicators of the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals – 2022-2023.